[Annual meeting of the American Association for Cancer Research].
Lavelle
F
F
Société française du cancer, 34, rue d'Ulm, 75231 Paris Cedex 05.
Armand
J P
JP
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002450:Cell Communication; D005544:Forecasting; D015972:Gene Expression Regulation, Neoplastic; D016147:Genes, Tumor Suppressor; D006801:Humans; D008495:Medical Oncology / Q000639:trends*; D051379:Mice; D009369:Neoplasms / Q000235:genetics / Q000628:therapy; D017239:Paclitaxel / Q000627:therapeutic use; D012106:Research; D012495:San Francisco; D012955:Societies, Medical
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D017239:Paclitaxel